Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Public-Private Partnership Helps Fund Superbug Fight

Forge Therapeutics recently took in more funding — up to $11.1 million — to battle life-threatening infections called “superbugs.”

San Diego Businesses Found Lacking in Female Board Members

Under a new law, California public companies must have at least one woman on their board by the end of 2019. It appears the biggest impact will be in San Diego.

Tease photo

Mirati Shines at Healthcare Conference

At the annual J.P. Morgan Healthcare conference, major San Diego players like Illumina naturally command attention. But quietly, Mirati Therapeutics had a strong showing.

Retrophin Names New CEO

Earlier this month San Diego-based Retrophin’s board appointed a new president and CEO: Eric Dube.

Ligand’s Stock Falls as Analysts Debate Value

PHARMA: Co. Confident in Revenue, Cash and Portfolio

Ligand Pharmaceutical’s stock has lost more than half of its value since October, puzzling the company and most analysts, though a vocal minority are skeptical of the company’s pipeline.

Tease photo

Jan Caldwell Becomes Chairman of Scripps Health Board

Jan Caldwell, who has sat on Scripps Health’s board since 2012, was named board chairman, it was announced Jan. 14.

Cirius Therapeutics Outlines $86M IPO Plans

Liver drug developer Cirius Therapeutics on Jan. 11 put in a prospectus for an $86 million initial public offering.

State’s First Accredited Senior Emergency Department Opens in San Diego

UC San Diego Health has opened a new senior emergency department, complete with a team trained in geriatric medicine and senior-friendly architectural design.

Government Shutdown Puts Brakes on IPO Plans

The federal government shutdown has stalled San Diego biotechs knocking on the door of an initial public offering.

Salk Board Gives Interim President a Five Year Term

The Salk Institute’s board recently voted to give President Rusty Gage a five-year job extension.

Poseida Therapeutics Files for $115M IPO

Poseida Therapeutics on Jan. 4 filed for an initial public offering, seeking to raise $115 million.

Local Biotech Stocks Stumble and Fall With Market Drop

San Diego’s biotech industry took a beating as part of a larger fourth quarter stock retreat.

Tease photo

NuVasive Shakes Up Organizational Structure

San Diego medtech NuVasive cut two vice president positions and shifted the responsibilities of other management as part of a reorganization that the company announced Jan. 3.

Roswell Biotechnologies Lands $32 Million Series A Round

Roswell Biotechnologies has taken in a $32 million series A round in a bid to bring down the cost of DNA sequencing through what the company calls a molecular electronics platform.

Ligand to Pay $10 Million to Palvella In Exchange for Royalty Rights

San Diego-based Ligand Pharmaceuticals will pay $10 million to Palvella Therapeutics under a recent deal.